Abstract
Most of the techniques used in structure-based drug design have experienced significant improvements in the past few years, resulting in a marked enhancement of the speed and the efficacy of this approach. At the same time, it was thought that the future of drug design lay in strategies involving solely combinatorial chemistry. It is becoming evident, however, that the development of future drugs will use a combination of methods that will contain a major component of structure-based design.
Original language | English (US) |
---|---|
Pages (from-to) | 366-369 |
Number of pages | 4 |
Journal | Current Opinion in Biotechnology |
Volume | 9 |
Issue number | 4 |
DOIs | |
State | Published - Aug 1998 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biomedical Engineering